HOME › DRUGS › ELTROMBOPAG
ACTIVE SUBSTANCE / INN

ELTROMBOPAG

Brand name(s): ELTROMBOPAG, Eltrombopag Accord, Revolade, Eltrombopag Viatris
FDA LISTED
EMA LISTED
AUTHORISED
NONE (TENTATIVE APPROVAL)
Purpura, Thrombocytopenic, Idiopathic;Anemia, Aplastic
Purpura, Thrombocytopenic, Idiopathic
ACTIVE SUBSTANCE
Eltrombopag
REGULATORS
FDA · EMA
SPONSORS / MAH
DR REDDYS LABS LTD, Viatris Limited, Accord Healthcare S.L.U.
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ELTROMBOPAGANDA219121DR REDDYS LABS LTDNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RevoladeNovartis Europharm LimitedAuthorised11/03/2010Purpura, Thrombocytopenic, Idiopathic;Anemia, Aplastic
Eltrombopag AccordAccord Healthcare S.L.U.Authorised28/03/2025Purpura, Thrombocytopenic, Idiopathic
Eltrombopag ViatrisViatris LimitedAuthorised12/12/2024Purpura, Thrombocytopenic, Idiopathic

FULL INTELLIGENCE ON ELTROMBOPAG

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →